Status:
UNKNOWN
Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus
Lead Sponsor:
Universidade Federal do Rio de Janeiro
Conditions:
Dry Eye Syndromes
HIV Seropositivity
Eligibility:
All Genders
18-45 years
Phase:
PHASE4
Brief Summary
This study evaluates the use of topical cyclosporine 0.05% and sodium carboxymethylcellulose 0.5% for the treatment of dry eye disease in patients infected with the human immunodeficiency virus. Twen...
Eligibility Criteria
Inclusion
- HIV seropositivity
- Dry eye diagnosis
Exclusion
- Hepatitis B infection
- Hepatitis C infection
- Menopause
- Rheumatic diseases
- Contact lens wear
- Beta-blocker eye drops
- Blepharitis
- Use of medications associated with dry eye (diuretics, antidepressive agents, beta-blockers)
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00797030
Start Date
October 1 2006
End Date
November 1 2008
Last Update
November 24 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade Federal do Rio de Janeiro
Rio de Janeiro, Rio de Janeiro, Brazil, 21941-913